Literature DB >> 16334972

A comparison of psychosocial and physical functioning in patients with motor neurone disease and metastatic cancer.

David M Clarke1, Janet E McLeod, Graeme C Smith, Tom Trauer, David W Kissane.   

Abstract

Although their disease processes and treatments are different, patients with motor neurone disease (MND) and those with late-stage cancer share a common situation--one in which the quality of life, rather than a cure, becomes the focus of care. We report here a comparison of 126 patients with MND and 125 with metastatic cancer on a range of physical and psychosocial measures. Compared to cancer patients, MND patients were younger, had greater social contacts, but were more physically impaired. Cancer patients had more pain and were on more medication (opioids, steroids, and analgesics). Although the Beck depression scores were similar in both groups, MND patients had significantly higher scores for demoralization, hopelessness, and suicidal ideation. Cancer patients, on the other hand, scored significantly higher on anhedonia. We suggest this difference in the quality of depression represents a difference in illness experience of the two groups and has relevance for the ways we treat depression in the medically ill.

Entities:  

Mesh:

Year:  2005        PMID: 16334972

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  10 in total

1.  Demoralization in medical practice.

Authors:  Juliet C Jacobsen; Guy Maytal; Theodore A Stern
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 2.  Palliative care and neurology: time for a paradigm shift.

Authors:  Isabel Boersma; Janis Miyasaki; Jean Kutner; Benzi Kluger
Journal:  Neurology       Date:  2014-07-02       Impact factor: 9.910

3.  Dignity therapy for people with motor neuron disease and their family caregivers: a feasibility study.

Authors:  Samar M Aoun; Harvey M Chochinov; Linda J Kristjanson
Journal:  J Palliat Med       Date:  2015-01       Impact factor: 2.947

4.  Temporal Proteomics of Inducible RNAi Lines of Clp Protease Subunits Identifies Putative Protease Substrates.

Authors:  Juan C Moreno; Silvia Martínez-Jaime; Joram Schwartzmann; Daniel Karcher; Michael Tillich; Alexander Graf; Ralph Bock
Journal:  Plant Physiol       Date:  2017-12-11       Impact factor: 8.340

Review 5.  Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease.

Authors:  Johannes Brettschneider; Jerome Kurent; Albert Ludolph
Journal:  Cochrane Database Syst Rev       Date:  2013-06-05

Review 6.  Neuropalliative Care: A Practical Guide for the Neurologist.

Authors:  K Brizzi; C J Creutzfeldt
Journal:  Semin Neurol       Date:  2018-10-15       Impact factor: 3.420

7.  Emotional distress and well-being among people with motor neurone disease (MND) and their family caregivers: a qualitative interview study.

Authors:  Cathryn Pinto; Adam W A Geraghty; Lucy Yardley; Laura Dennison
Journal:  BMJ Open       Date:  2021-08-17       Impact factor: 3.006

8.  Is dignity therapy feasible to enhance the end of life experience for people with motor neurone disease and their family carers?

Authors:  Brenda Bentley; Samar M Aoun; Moira O'Connor; Lauren J Breen; Harvey Max Chochinov
Journal:  BMC Palliat Care       Date:  2012-09-20       Impact factor: 3.234

9.  Caregivers' Sensemaking of Children's Hereditary Angioedema: A Semiotic Narrative Analysis of the Sense of Grip on the Disease.

Authors:  Maria Francesca Freda; Livia Savarese; Pasquale Dolce; Raffaele De Luca Picione
Journal:  Front Psychol       Date:  2019-11-27

10.  Determine the Symptom Intensities, Performance and Hopelessness Levels of Advanced Lung Cancer Patients for the Palliative Care Approach.

Authors:  Esra Dogan; Hanife Ozcelik
Journal:  Am J Hosp Palliat Care       Date:  2022-03-02       Impact factor: 2.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.